A Protocolized Management of Walled-Off Necrosis (WON) Reduces Time to WON Resolution and Improves Outcomes.


Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
09 2023
Historique:
received: 13 11 2022
revised: 21 04 2023
accepted: 27 04 2023
medline: 28 8 2023
pubmed: 11 5 2023
entrez: 10 5 2023
Statut: ppublish

Résumé

Patients with infected or symptomatic walled-off necrosis (WON) have high morbidity and health care utilization. Despite the recent adoption of nonsurgical treatment approaches, WON management remains nonalgorithmic. We investigated the impact of a protocolized early necrosectomy approach compared with a nonprotocolized, clinician-driven approach on important clinical outcomes. Records were reviewed for consecutive patients with WON who underwent a protocolized endoscopic drainage with a lumen-apposing metal stent (cases), and for patients with WON treated with a lumen-apposing metal stent at the same tertiary referral center who were not managed according to the protocol (control subjects). The protocol required repeat cross-sectional imaging within 14 days after lumen-apposing metal stent placement, with regularly scheduled endoscopic necrosectomy if WON diameter reduction was <50%. Control patients were treated according to their clinician's preference without an a priori strategy. Inverse probability of treatment weighting-adjusted analysis was used to evaluate the influence of being in the protocolized group on time to resolution. A total of 24 cases and 47 control subjects were included. There were no significant differences in baseline characteristics. Although numbers of endoscopies and necrosectomies were similar, cases had lower adverse event rates, shorter intensive care unit stay, and required nutritional support for fewer days. On matched multivariate Cox regression, cases had earlier WON resolution (hazard ratio, 5.73; 95% confidence interval, 2.62-12.5). This was confirmed in the inverse probability of treatment weighting-adjusted analysis (hazard ratio, 3.4; 95% confidence interval, 1.92-6.01). A protocolized strategy resulted in faster WON resolution compared with a discretionary approach without the need for additional therapeutic interventions, and with a better safety profile and decreased health care utilization.

Sections du résumé

BACKGROUND AND AIMS
Patients with infected or symptomatic walled-off necrosis (WON) have high morbidity and health care utilization. Despite the recent adoption of nonsurgical treatment approaches, WON management remains nonalgorithmic. We investigated the impact of a protocolized early necrosectomy approach compared with a nonprotocolized, clinician-driven approach on important clinical outcomes.
METHODS
Records were reviewed for consecutive patients with WON who underwent a protocolized endoscopic drainage with a lumen-apposing metal stent (cases), and for patients with WON treated with a lumen-apposing metal stent at the same tertiary referral center who were not managed according to the protocol (control subjects). The protocol required repeat cross-sectional imaging within 14 days after lumen-apposing metal stent placement, with regularly scheduled endoscopic necrosectomy if WON diameter reduction was <50%. Control patients were treated according to their clinician's preference without an a priori strategy. Inverse probability of treatment weighting-adjusted analysis was used to evaluate the influence of being in the protocolized group on time to resolution.
RESULTS
A total of 24 cases and 47 control subjects were included. There were no significant differences in baseline characteristics. Although numbers of endoscopies and necrosectomies were similar, cases had lower adverse event rates, shorter intensive care unit stay, and required nutritional support for fewer days. On matched multivariate Cox regression, cases had earlier WON resolution (hazard ratio, 5.73; 95% confidence interval, 2.62-12.5). This was confirmed in the inverse probability of treatment weighting-adjusted analysis (hazard ratio, 3.4; 95% confidence interval, 1.92-6.01).
CONCLUSIONS
A protocolized strategy resulted in faster WON resolution compared with a discretionary approach without the need for additional therapeutic interventions, and with a better safety profile and decreased health care utilization.

Identifiants

pubmed: 37164115
pii: S1542-3565(23)00329-4
doi: 10.1016/j.cgh.2023.04.029
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2543-2550.e1

Informations de copyright

Copyright © 2023 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Serge Baroud (S)

Department of Internal Medicine, MetroHealth Medical Center and Case Western Reserve University, Cleveland, Ohio.

Vinay Chandrasekhara (V)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Andrew C Storm (AC)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Ryan J Law (RJ)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Eric J Vargas (EJ)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Michael J Levy (MJ)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Tala Mahmoud (T)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Fateh Bazerbachi (F)

St. Cloud Interventional Endoscopy Program, CentraCare, St. Cloud Hospital, St. Cloud, Minnesota.

Aliana Bofill-Garcia (A)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Rabih Ghazi (R)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Daniel B Maselli (DB)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

John A Martin (JA)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Santhi Swaroop Vege (SS)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Naoki Takahashi (N)

Division of Radiology, Mayo Clinic, Rochester, Minnesota.

Bret T Petersen (BT)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Mark D Topazian (MD)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Barham K Abu Dayyeh (BK)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: abudayyeh.barham@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH